Preparation and evaluation of tumor-targeting peptide−oligonucleotide conjugates

Enormous progress has been made in the development of antisense oligodeoxynucleotides (ODNs) as therapeutic agents inhibiting gene expression. Unfortunately, the therapeutical application of ODNs is still held back because of the low cellular uptake and the lack of specific transport into particular...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mier, Walter (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Eisenhut, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: October 28, 2000
In: Bioconjugate chemistry
Year: 2000, Jahrgang: 11, Heft: 6, Pages: 855-860
ISSN:1520-4812
DOI:10.1021/bc000041k
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1021/bc000041k
Volltext
Verfasserangaben:Walter Mier, Ramon Eritja, Ashour Mohammed, Uwe Haberkorn, and Michael Eisenhut

MARC

LEADER 00000caa a2200000 c 4500
001 1747887668
003 DE-627
005 20230426111246.0
007 cr uuu---uuuuu
008 210209s2000 xx |||||o 00| ||eng c
024 7 |a 10.1021/bc000041k  |2 doi 
035 |a (DE-627)1747887668 
035 |a (DE-599)KXP1747887668 
035 |a (OCoLC)1341392119 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Mier, Walter  |d 1966-  |e VerfasserIn  |0 (DE-588)12029026X  |0 (DE-627)69653567X  |0 (DE-576)292141599  |4 aut 
245 1 0 |a Preparation and evaluation of tumor-targeting peptide−oligonucleotide conjugates  |c Walter Mier, Ramon Eritja, Ashour Mohammed, Uwe Haberkorn, and Michael Eisenhut 
264 1 |c October 28, 2000 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.02.2021 
520 |a Enormous progress has been made in the development of antisense oligodeoxynucleotides (ODNs) as therapeutic agents inhibiting gene expression. Unfortunately, the therapeutical application of ODNs is still held back because of the low cellular uptake and the lack of specific transport into particular cells. In this paper, we report a drug-targeting system using somatostatin receptors (SSTRs) which are overexpressed in various tumors. Phosphorothioate ODNs were covalently linked to Tyr3−octreotate, an analogue of somatostatin. The peptide was assembled by solid-phase synthesis, oxidized to form the cyclic disulfide, and subsequently derivatized with a N-terminal maleimido functionality. 5‘-Thiol derivatized phosphorothioate-ODNs directed against the protooncogene bcl-2 were conjugated to this maleimido-modified peptide. Binding studies revealed that the conjugates retain specific binding with nanomolar affinities to SSTRs (IC50-values between 1.83 and 2.52 nM). Furthermore, melting studies with complementary DNA revealed that the terminal conjugation of the ODNs did not significantly affect their hybridization affinity. 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
700 1 |a Eisenhut, Michael  |e VerfasserIn  |0 (DE-588)1113306122  |0 (DE-627)867174501  |0 (DE-576)160846080  |4 aut 
773 0 8 |i Enthalten in  |t Bioconjugate chemistry  |d Columbus, Ohio : American Chemical Society, 1990  |g 11(2000), 6, Seite 855-860  |h Online-Ressource  |w (DE-627)306655780  |w (DE-600)1500067-9  |w (DE-576)088732371  |x 1520-4812  |7 nnas  |a Preparation and evaluation of tumor-targeting peptide−oligonucleotide conjugates 
773 1 8 |g volume:11  |g year:2000  |g number:6  |g pages:855-860  |g extent:6  |a Preparation and evaluation of tumor-targeting peptide−oligonucleotide conjugates 
856 4 0 |u https://doi.org/10.1021/bc000041k  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210209 
993 |a Article 
994 |a 2000 
998 |g 1113306122  |a Eisenhut, Michael  |m 1113306122:Eisenhut, Michael  |d 50000  |e 50000PE1113306122  |k 0/50000/  |p 5  |y j 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 4 
998 |g 12029026X  |a Mier, Walter  |m 12029026X:Mier, Walter  |d 910000  |d 911400  |e 910000PM12029026X  |e 911400PM12029026X  |k 0/910000/  |k 1/910000/911400/  |p 1  |x j 
999 |a KXP-PPN1747887668  |e 3850343243 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1747887668","person":[{"role":"aut","family":"Mier","display":"Mier, Walter","given":"Walter"},{"given":"Uwe","display":"Haberkorn, Uwe","role":"aut","family":"Haberkorn"},{"role":"aut","family":"Eisenhut","given":"Michael","display":"Eisenhut, Michael"}],"note":["Gesehen am 09.02.2021"],"name":{"displayForm":["Walter Mier, Ramon Eritja, Ashour Mohammed, Uwe Haberkorn, and Michael Eisenhut"]},"language":["eng"],"relHost":[{"recId":"306655780","name":{"displayForm":["American Chemical Society"]},"origin":[{"publisher":"American Chemical Society","dateIssuedDisp":"1990-","dateIssuedKey":"1990","publisherPlace":"Columbus, Ohio"}],"title":[{"title":"Bioconjugate chemistry","title_sort":"Bioconjugate chemistry"}],"id":{"zdb":["1500067-9"],"issn":["1520-4812"],"eki":["306655780"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 18.11.08"],"pubHistory":["1.1990 -"],"language":["eng"],"part":{"year":"2000","volume":"11","extent":"6","pages":"855-860","issue":"6","text":"11(2000), 6, Seite 855-860"},"disp":"Preparation and evaluation of tumor-targeting peptide−oligonucleotide conjugatesBioconjugate chemistry","type":{"bibl":"periodical","media":"Online-Ressource"}}],"origin":[{"dateIssuedDisp":"October 28, 2000","dateIssuedKey":"2000"}],"title":[{"title":"Preparation and evaluation of tumor-targeting peptide−oligonucleotide conjugates","title_sort":"Preparation and evaluation of tumor-targeting peptide−oligonucleotide conjugates"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"id":{"doi":["10.1021/bc000041k"],"eki":["1747887668"]},"physDesc":[{"extent":"6 S."}]} 
SRT |a MIERWALTERPREPARATIO2820